A Multi‐Modal Medical Management and Lifestyle Randomized Clinical Trial Increases Cerebral Blood Flow and Lowers Diabetic Risk in Persons with Early Alzheimer's Disease: Results from The [PREVENTION] Trial

Abstract

Background: Medical and lifestyle management are crucial for Alzheimer's disease (AD). Cerebral blood flow (CBF), vital for brain health, is reduced in AD, and influenced by modifiable risk factors. Method: The PREVENTION study is an ongoing randomized clinical trial (McEwen, 2021).